grant

Harnessing synthetic biology to develop new gene therapies for difficult-to-treat diseases

Also known as: Investigator Grants

Funded by National Health and Medical Research Council
Managed by Curtin University
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/2025514]

Funding Amount $2,697,165.00

Full description Synthetic biology is revolutionizing the programming of molecules and cells with new functions. Professor Rackham is a pioneer in this field and is harnessing the tremendous potential of synthetic biology to create new therapeutic technologies. These include protein-based gene therapies to cure inherited genetic diseases and cancer. The impacts of these new technologies are already being realised through collaborations with industry and dissemination of critical new knowledge.

Chief Investigator Prof Oliver Rackham

Date Announced 2023-12-15T00:00:00

Sector University

Click to explore relationships graph
Help

Related Organisations

Spatial Coverage And Location

text: WA

Subjects
Biochemistry and Cell Biology | Biological Sciences | Basic Science Research | Gene and Molecular Therapy | Medical Biotechnology | Synthetic Biology | Technology | biomedical and clinical sciences | gene expression | gene therapy | inherited metabolic disorders | mitochondria | protein engineering |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA